Low back pain MRI
```
|
Low back pain Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low back pain MRI On the Web |
|
American Roentgen Ray Society Images of Low back pain MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Keanu Ngo[2]
Overview
Lumbar MRI is the preferred advanced imaging modality for low back pain (LBP) when imaging is indicated, because it shows discs, neural elements, bone marrow and epidural space without ionizing radiation.[1] Routine imaging, including MRI, is not recommended for nonspecific LBP.[2][3] Degenerative findings are common in people without pain, so most MRI findings have limited specificity.[3]
Indications
- Not indicated for acute or chronic nonspecific LBP without features of serious pathology (history of cancer, fever, trauma, new bladder or bowel dysfunction).[3]
- Emergent MRI: suspected cauda equina syndrome (new urinary retention or incontinence, saddle anesthesia, progressive lower-extremity motor weakness; about 0.1% of primary care LBP presentations) requires immediate MRI and urgent neurosurgical evaluation.[3]
- Serious pathology: a history of cancer raises the posttest probability of spinal malignancy to 33% (95% CI, 22%-46%). Risk factors for vertebral infection (fever, intravenous drug use, recent infection or spinal procedure) and features suggesting axial spondyloarthritis (onset before age 45, morning stiffness of at least 30 minutes, improvement with exercise but not rest, alternating buttock pain, night waking) warrant considering MRI. Multiple red flags together increase concern further, although data on red-flag combinations are limited.[3]
- Persistent symptoms: indicated when LBP with or without nerve-root involvement does not abate with conservative care, particularly if the patient is a candidate for surgery or intervention.[2][1]
- Older adults: early imaging in adults aged 65 years or older with acute LBP without radiculopathy was not associated with improved 1-year outcomes.[2]
- Appropriateness criteria vary: studies applying ACR Appropriateness Criteria used imaging for symptoms under 6 weeks plus a red flag (e.g., history of malignancy, unexplained weight loss, immunosuppression, IV drug use, prolonged corticosteroids, significant trauma, progressive motor weakness), or symptoms beyond 6 weeks not improved with conservative therapy. Studies referencing ACP/APS guidance used a 4-week threshold. Symptom-duration thresholds and red-flag lists differ across guidelines.[4]
- Real-world overuse: an estimated 20-50% of lumbar MRIs lack a clear clinical indication. In a single-center prospective surgeon-based study, clinic-radiologic concordance was 70.4%, and surgeons' pre-MRI expectation of usefulness predicted whether MRI changed treatment. Neurological symptoms and psychosocial (yellow flag) status did not predict MRI usefulness in that cohort.[5]
Protocol
- Standard: T1- and T2-weighted sagittal and axial sequences without contrast.[1]
- Add fat-suppressed or STIR sequences for marrow edema, infection, tumor and inflammatory disease.[6]
- Gadolinium is not needed for routine degenerative disease. It is used for suspected infection or tumor, and in patients with prior lumbar surgery to distinguish scar (enhances) from recurrent disc material (little or no enhancement).[7][1]
Degenerative findings and their clinical relevance
- Degenerative changes on MRI were present in 77.8% of participants with LBP and 74.4% without LBP in a cohort of 3369 adults; prevalence rose with age (about 50% under age 41, over 90% over age 69).[3]
- Disc degeneration at any level in people without LBP increased from 38.1% (age 41-49) to 58.1% (50-59) and 81.9% (60-68).[3]
- Over-attribution of symptoms to incidental findings can cause anxiety, inappropriate diagnosis and unnecessary treatment.[3]
| Finding | Association with LBP | Source |
|---|---|---|
| Disc bulge, disc extrusion, disc protrusion, disc degeneration, Modic type 1, spondylolysis | More prevalent in symptomatic adults aged 50 years or younger (meta-analysis, 14 studies, 3097 individuals); ORs 2.24 (disc degeneration) to 7.54 (disc bulge) with wide CIs for some | [8] |
| Any Modic change, central canal stenosis, high-intensity zone, annular fissure, spondylolisthesis | Not significantly associated in the same meta-analysis | [8] |
| Modic changes, anterolisthesis | Strongest associations in 412 40-year-olds (OR >4); hypointense disc signal and reduced disc height also associated | [9] |
| Modic changes (any, type 1) | Associated with prolonged disabling LBP at age 47 (adjusted OR 1.50 for each); larger changes had higher odds | [10] |
| Number of structural abnormalities | Greater number associated with greater odds of chronic and intermittent LBP, disability and lower quality of life (cross-sectional, n=712) | [11] |
Associations are age- and level-dependent: in a comparison of symptomatic and asymptomatic women, differences were largest in the lower lumbar spine and before age 60, and narrowed with age.[12]
Modic changes
- Type 1: low T1, high T2 signal (marrow edema/inflammation); more strongly linked to pain.
- Type 2: high T1 and T2 signal (fatty replacement); more chronic, weaker pain correlation.
- Type 3: low T1 and T2 signal (sclerosis).[13]
- Prevalence in non-clinical populations is about 6-24% (range 0.5-88%), rising with age; in chronic LBP it exceeds 40%, mostly type 2 at L4/L5 and L5/S1. Evidence for a pain association is described as inconsistent across reviews.[13]
- Modic-like changes also occur with infection and inflammatory disease, so correlation with clinical context is required.
Findings by specific diagnosis
- Disc herniation/radiculopathy: protrusion or extrusion with nerve root contact or displacement. MRI is comparable to CT and myelography for herniated disc detection against surgical findings, so concordance with dermatomal symptoms and examination is required.[7][14]
- Spinal stenosis: central, lateral recess or foraminal narrowing; MRI and CT are similarly accurate, and severity grading is not reliably tied to symptoms.[14]
- Cauda equina syndrome: compression of the lumbosacral roots; emergent MRI.[3]
- Spondylodiscitis/epidural abscess: MRI should be the first imaging modality (reported sensitivity 96%, specificity 92%, accuracy 94%) and can be positive within 2 weeks of onset in more than 50% of cases. Findings are endplate-adjacent marrow edema (low T1, high T2 signal), enhancement, loss of the intranuclear cleft on T2, endplate erosion, and paraspinal or epidural collections. If early MRI is nondiagnostic and symptoms persist, repeat MRI after a few days. Follow-up MRI is usually not indicated because findings can worsen despite clinical improvement.[6]
- Metastasis/myeloma: marrow replacement (low T1 signal), pathologic fracture, epidural extension. MRI with gadolinium is the most sensitive study for paravertebral soft tissue and intradural pathology.[14]
- Vertebral compression fracture: marrow edema on STIR indicates acute fracture and helps distinguish acute from chronic and benign from malignant fractures.
- Axial spondyloarthritis: sacroiliac joint bone marrow edema on STIR; structural lesions on T1 (see Low back pain other imaging findings).
- Spondylolysis: pars defect; marrow edema in early stress reaction.
Limitations
- Findings such as disc bulge, annular fissure, facet degeneration and Modic changes occur in asymptomatic people and are age-related.[9][3]
- Reports should state that degenerative findings are common and often incidental.
- Psychosocial factors and nonspecific pain syndromes confound localization; in one cohort, coexistent joint pain was associated with poorer clinic-MRI concordance.[5]
- Contraindications: incompatible implants or devices (verify MRI conditionality) and severe claustrophobia (sedation or open scanner).
- Gadolinium and renal function: nephrogenic systemic fibrosis (NSF) is a rare condition in patients with kidney failure, linked mainly to ACR group I agents. Group II and III agents are lower risk, and NSF has largely been eliminated with their use.[15] For group II agents (gadobutrol, gadoteridol, gadoterate, gadobenate), ACR considers renal screening optional. Group I or III agents or above-standard doses require renal function assessment.[16] US labels carry a boxed warning for NSF.[17]
- Gadolinium retention: trace deposition occurs with all agents (more with linear than macrocyclic), and no adverse clinical effects have been demonstrated.[15]
- Gadolinium in pregnancy: agents cross the placenta; human data are limited and inconclusive, and one retrospective cohort reported more stillbirths and neonatal deaths after exposure. The gadobutrol US label advises use only if imaging is essential and cannot be delayed.[18][19]
Areas of uncertainty
- Causal role of Modic changes and high-intensity zones is unresolved.[13][8]
- Most data are cross-sectional; associations in symptomatic versus asymptomatic cohorts differ by age, level and population.[12]
- Appropriateness criteria differ across guidelines, and the evidence base for MRI-guided treatment decisions is limited.[4]
References
- ↑ 1.0 1.1 1.2 1.3 Urits I, Burshtein A, Sharma M, et al. Low Back Pain, a Comprehensive Review: Pathophysiology, Diagnosis, and Treatment. Curr Pain Headache Rep. 2019.
- ↑ 2.0 2.1 2.2 Chiarotto A, Koes BW. Nonspecific Low Back Pain. N Engl J Med. 2022.
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 Cashin AG, Chou R, Weimer MB, McAuley JH. Low Back Pain: A Review. JAMA. 2026.
- ↑ 4.0 4.1 Yates M, Oliveira CB, Galloway JB, Maher CG. Defining and measuring imaging appropriateness in low back pain studies: a scoping review. Eur Spine J. 2020.
- ↑ 5.0 5.1 Kanna RM, Aravindhan S, Shetty AP, Rajasekaran S. Pertinence of magnetic resonance imaging in lumbar pain: a prospective surgeon-based evaluation of diagnostic concordance and therapeutic impact. Eur Spine J. 2026.
- ↑ 6.0 6.1 Lazzeri E, Bozzao A, Cataldo MA, et al. Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults. Eur J Nucl Med Mol Imaging. 2019.
- ↑ 7.0 7.1 Edelman RR, Warach S. Magnetic Resonance Imaging. N Engl J Med. 1993.
- ↑ 8.0 8.1 8.2 Brinjikji W, et al. MRI findings of disc degeneration are more prevalent in adults with low back pain than in asymptomatic controls. AJNR Am J Neuroradiol. 2015. PMID 26359154.
- ↑ 9.0 9.1 Kjaer P, et al. Magnetic resonance imaging and low back pain in adults. Spine. 2005. PMID 15897832.
- ↑ Saukkonen J, et al. Association between Modic changes and low back pain in middle age. Spine. 2020. PMID 32341297.
- ↑ Yang D, et al. Association between MRI findings of lumbar morphometric changes and characteristics of low back pain. Acad Radiol. 2025. PMID 40640053.
- ↑ 12.0 12.1 Jamaludin A, et al. ISSLS Prize 2023: comparison of degenerative MRI features of the intervertebral disc between those with and without chronic low back pain. Eur Spine J. 2023.
- ↑ 13.0 13.1 13.2 Mitchell UH, et al. Modic changes, chronic low back pain, and lifestyle and mental health factors. Eur Spine J. 2026.
- ↑ 14.0 14.1 14.2 Atlas SJ, Nardin RA. Evaluation and treatment of low back pain: an evidence-based approach to clinical care. Muscle Nerve. 2003.
- ↑ 15.0 15.1 Starekova J, Pirasteh A, Reeder SB. Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media. AJR Am J Roentgenol. 2024. PMID 37850581.
- ↑ Ponrartana S, Moore MM, Chan SS, et al. Safety issues related to intravenous contrast agent use in magnetic resonance imaging. Pediatr Radiol. 2021.
- ↑ Levine D, McDonald RJ, Kressel HY. Gadolinium Retention After Contrast-Enhanced MRI. JAMA. 2018.
- ↑ US Food and Drug Administration. Gadobutrol injection, prescribing information (Use in Specific Populations).
- ↑ Proença F, Guerreiro C, Sá G, Reimão S. Neuroimaging safety during pregnancy and lactation: a review. Neuroradiology. 2021.